CN105561202A - Traditional Chinese medicine composition for treating uterus cancer - Google Patents
Traditional Chinese medicine composition for treating uterus cancer Download PDFInfo
- Publication number
- CN105561202A CN105561202A CN201610075509.1A CN201610075509A CN105561202A CN 105561202 A CN105561202 A CN 105561202A CN 201610075509 A CN201610075509 A CN 201610075509A CN 105561202 A CN105561202 A CN 105561202A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 208000002495 Uterine Neoplasms Diseases 0.000 title abstract 3
- 206010046766 uterine cancer Diseases 0.000 title abstract 3
- 239000008280 blood Substances 0.000 claims abstract description 62
- 210000004369 blood Anatomy 0.000 claims abstract description 61
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 38
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 30
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 30
- 241000628997 Flos Species 0.000 claims abstract description 28
- 241000903946 Clematidis Species 0.000 claims abstract description 24
- 235000003650 acai Nutrition 0.000 claims abstract description 17
- 241000220215 Moringa Species 0.000 claims description 37
- 239000000843 powder Substances 0.000 claims description 36
- 241000190633 Cordyceps Species 0.000 claims description 30
- 208000012991 uterine carcinoma Diseases 0.000 claims description 28
- 239000009969 fructus bruceae Substances 0.000 claims description 24
- 241000283956 Manis Species 0.000 claims description 23
- 244000207620 Euterpe oleracea Species 0.000 claims description 16
- 235000012601 Euterpe oleracea Nutrition 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 241000158621 Brucea Species 0.000 claims description 15
- 229920000858 Cyclodextrin Polymers 0.000 claims description 14
- 229940064008 acai berry extract Drugs 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000001116 FEMA 4028 Substances 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 235000015800 acai extract Nutrition 0.000 claims description 7
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 7
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 7
- 229960004853 betadex Drugs 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 235000019359 magnesium stearate Nutrition 0.000 claims description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 7
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 14
- 201000011510 cancer Diseases 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000004087 circulation Effects 0.000 abstract description 3
- 241000283966 Pholidota <mammal> Species 0.000 abstract 2
- 241000233866 Fungi Species 0.000 abstract 1
- 241001505523 Gekko gecko Species 0.000 abstract 1
- 241001558017 Gynura Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000179886 Moringa oleifera Species 0.000 abstract 1
- 240000001307 Myosotis scorpioides Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000097577 Rhus javanica Species 0.000 abstract 1
- 235000010889 Rhus javanica Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010008342 Cervix carcinoma Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 201000010881 cervical cancer Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000025421 tumor of uterus Diseases 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- KDPFMRXIVDLQKX-ISGXEFFDSA-N (+)-Curdione Natural products CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)/CC1=O KDPFMRXIVDLQKX-ISGXEFFDSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- KDPFMRXIVDLQKX-NHFJXKHHSA-N Germacr-1(10)-ene-5,8-dione Chemical compound CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)\CC1=O KDPFMRXIVDLQKX-NHFJXKHHSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000448 cultured tumor cell Anatomy 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- KDPFMRXIVDLQKX-UHFFFAOYSA-N curdione Natural products CC(C)C1CC(=O)C(C)CCC=C(C)CC1=O KDPFMRXIVDLQKX-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating uterus cancer. The traditional Chinese medicine composition is mainly prepared from, by weight, 3-10 parts of tokay gecko, 4-10 parts of raw pangolin scale, 1-5 parts of pangolin blood, 1-3 parts of java brucea fruit, 1-3 parts of radix sophorae subprostratae, 8-18 parts of horseradish tree, 5-16 parts of acai berry, 5-15 parts of divaricate gynura root, 10-30 parts of flos notoginseng, 8-25 parts of rhizome ligusticum wallichii, 8-25 parts of radix angelicae sinensis, 2-7 parts of flos carthami, 2-8 parts of rhizoma curcumae, 2-8 parts of dragon blood, 1-5 parts of radix gentianae, 5-15 parts of herba dendrobii, 2-6 parts of Chinese caterpillar fungus, 2-6 parts of American ginseng, 4-10 parts of radix clematidis and 8-40 parts of liquorice root. Through reasonable compatibility of traditional Chinese medicines, the traditional Chinese medicine composition can support the healthy energy, promote blood circulation to remove blood stasis, promote qi circulation to relieve pain, prevent cancer cells and improve the immunity of the organism, so that uterus cancer can be treated.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly a kind of Chinese medicine composition for the treatment of uterus carcinoma.
Background technology
Uterus carcinoma is one of modal malignant tumor of gynecological, and uterus carcinoma comprises carcinoma of corpus uteri (also known as carcinoma of endometrium) and cervical cancer.In the world, about have more than 20 ten thousand women to die from cervical cancer every year, in developing country, cervical cancer then belongs to common multiple gynecological tumor, the seniority among brothers and sisters umber one.Uterus carcinoma refers to the malignant tumor occurring in utero vaginal portion and cervical canal, the transfer of cervical cancer, can to adjacent tissue and organ direct extension, down to fornix vaginae and vaginal wall, upwards can invade body of uterus, can pelvic tissue be invaded to both sides, can bladder be invaded forward, can rectum be invaded backward.
Be intended to the Chinese medicine for the treatment of uterus tumor at present, mainly there is the deficiency of several aspect: one is that drug effect is not remarkable; Two be take effect slower; Three is can not treating both the principal and secondary aspects of a disease.A lot of uterus carcinoma patient effectively can not control growth, the metastasis and extension of tumor because of medicine, or drug administration does not recur again later, thus have impact on the time of existence.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of uterus carcinoma, have significant therapeutic effect to uterus carcinoma.
For achieving the above object, technical scheme of the present invention is:
Treat a Chinese medicine composition for uterus carcinoma, it is made by weight ratio primarily of following component:
Gecko 3 ~ 10 parts, raw first sheet 4 ~ 10 parts, Squama Manis blood 1 ~ 5 part, brucea 1 ~ 3 part, Radix Sophorae Tonkinensis 1 ~ 3 part, Moringa 8 ~ 18 parts, Brazilian Acai 5 ~ 16 parts, Radix et Rhizoma Gynurae divaricatae 5 ~ 15 parts, flower of Radix Notoginseng 10 ~ 30 parts, Rhizoma Chuanxiong 8 ~ 25 parts, Radix Angelicae Sinensis 8 ~ 25 parts, 2 ~ 7 parts, Flos Carthami, Rhizoma Curcumae 2 ~ 8 parts, brown 2 ~ 8 parts of blood, Radix Gentianae 1 ~ 5 part, Herba Dendrobii 5 ~ 15 parts, Cordyceps 2 ~ 6 parts, Radix Panacis Quinquefolii 2 ~ 6 parts, Radix Clematidis 4 ~ 10 parts, 8 ~ 40 parts, Radix Glycyrrhizae.
The Chinese medicine composition of the above treatment uterus carcinoma, its more specifically technical scheme be: it is made by weight ratio primarily of following component: Gecko 4 ~ 8 parts, raw first sheet 5 ~ 9 parts, Squama Manis blood 2 ~ 4 parts, brucea 1 ~ 3 part, Radix Sophorae Tonkinensis 1 ~ 3 part, Moringa 10 ~ 17 parts, Brazilian Acai 7 ~ 14 parts, Radix et Rhizoma Gynurae divaricatae 7 ~ 13 parts, flower of Radix Notoginseng 15 ~ 25 parts, Rhizoma Chuanxiong 10 ~ 22 parts, Radix Angelicae Sinensis 10 ~ 22 parts, 3 ~ 6 parts, Flos Carthami, Rhizoma Curcumae 3 ~ 7 parts, brown 3 ~ 6 parts of blood, Radix Gentianae 2 ~ 4 parts, Herba Dendrobii 7 ~ 13 parts, Cordyceps 3 ~ 5 parts, Radix Panacis Quinquefolii 3 ~ 5 parts, Radix Clematidis 6 ~ 8 parts, 12 ~ 35 parts, Radix Glycyrrhizae.
The Chinese medicine composition of the above treatment uterus carcinoma, preferably makes primarily of following component: Gecko 6 parts, raw first sheet 7 parts, Squama Manis blood 3 parts, brucea 2 parts, Radix Sophorae Tonkinensis 2 parts, Moringa 13 parts, Brazilian Acai 12 parts, Radix et Rhizoma Gynurae divaricatae 10 parts, flower of Radix Notoginseng 20 parts, Rhizoma Chuanxiong 17 parts, Radix Angelicae Sinensis 17 parts, 5 parts, Flos Carthami, Rhizoma Curcumae 5 parts, brown 5 parts of blood, Radix Gentianae 3 parts, Herba Dendrobii 10 parts, Cordyceps 4 parts, Radix Panacis Quinquefolii 4 parts, Radix Clematidis 7 parts, 17 parts, Radix Glycyrrhizae by weight ratio.
The Chinese medicine composition of the above treatment uterus carcinoma, can add by practice of pharmacy any dosage form that customary adjuvant makes clinical acceptance; As preferably, described dosage form is capsule.
Preferably, what described Moringa was selected is Moringa rhizome.
The preparation method of the Chinese medicine composition of above-described treatment uterus carcinoma, comprises the following steps:
(1) following component is taken by weight: Gecko 3 ~ 10 parts, raw first sheet 4 ~ 10 parts, Squama Manis blood 1 ~ 5 part, brucea 1 ~ 3 part, Radix Sophorae Tonkinensis 1 ~ 3 part, Moringa 8 ~ 18 parts, Brazilian Acai 5 ~ 16 parts, Radix et Rhizoma Gynurae divaricatae 5 ~ 15 parts, flower of Radix Notoginseng 10 ~ 30 parts, Rhizoma Chuanxiong 8 ~ 25 parts, Radix Angelicae Sinensis 8 ~ 25 parts, 2 ~ 7 parts, Flos Carthami, Rhizoma Curcumae 2 ~ 8 parts, brown 2 ~ 8 parts of blood, Radix Gentianae 1 ~ 5 part, Herba Dendrobii 5 ~ 15 parts, Cordyceps 2 ~ 6 parts, Radix Panacis Quinquefolii 2 ~ 6 parts, Radix Clematidis 4 ~ 10 parts, 8 ~ 40 parts, Radix Glycyrrhizae;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
The main Gecko of Chinese medicine composition of the present invention, raw first sheet, Squama Manis blood, brucea, Radix Sophorae Tonkinensis, Moringa, Brazilian Acai, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood are brown, Radix Gentianae, Herba Dendrobii, Cordyceps, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae composition, and in side, effect of each Chinese medicine is:
Gecko: record according to " Japan hanako materia medica ", can lung qi be controlled, antitussive, and logical menstruation, lower stranguria caused by urinary stone and control blood;
Raw first sheet: the routed carbuncle of detumescence, searches wind active, stimulating milk secretion of stimulating the menstrual flow; Be used for the treatment of carbuncle skin ulcer kind, anemofrigid-damp arthralgia, amenorrhea;
Squama Manis blood: be used for the treatment of stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, arthralgia, the diseases such as numbness contracture;
Brucea: Oleum Fructus Bruceae has good anticancer effect, is mainly used in pulmonary carcinoma, tumor that cervical cancer also has digestive tract aspect; Oleum Fructus Bruceae can carry out copying the increasing tumor cell of generation by inhibition tumor cell DNA on the one hand, directly can enter into the inside of cancer cell in addition on the one hand, then allow necrocytosis, be discharged to the external of human body, or engulfed by the phagocyte of human body;
Radix Sophorae Tonkinensis: have heat-clearing and toxic substances removing, effect of detumescence sore-throat relieving; Record according to " Bencao Jingshu ", Radix Sophorae Tonkinensis, sweet so and poison, cold so heat extraction, all malicious Bi Rebixin, obtain poor gas, the taste of sweetness and bitterness, then all poison are explained by oneself, therefore are the medicine-feeding of removing toxic substances heat clearing away;
Moringa: be the plant containing enriching high nutritive value, has the advantage of high protein, low lipid, high microsteping, homovitamin, containing its mineral such as life A, B, C and protein, calcium, potassium, ferrum etc. of dimension; Can physical strength reinforcing, treatment anemia, suppress pathogenic bacteria, drive away parasite;
Brazilian Acai: can help wound healing, purify the blood, improves anemia, diarrhoea, fever, hemorrhage, the disease such as jaundice, hepatic disease; Containing vitamin A, B1, B2, B3, B6 and B12, also have vitamin C, D, E and 17 kinds of essential minerals, polyphenoils wherein and vitamin A, C and E, effectively can accelerate human body cell growth, repair impaired skin;
Radix et Rhizoma Gynurae divaricatae: the effect with blood sugar lowering, clearing away heat and cooling blood, promoting blood circulation and stopping pain, hemostasis;
Flower of Radix Notoginseng: the effect with heat clearing away, suppressing the hyperactive liver, blood pressure lowering, research in recent years shows, containing anti-cancer active matters such as arasaponin, beta-elemene, trace element-selenium in Radix Notoginseng; The Rb1 of arasaponin 120ug/ml concentration can make cultured tumor cells 92% be suppressed, and the suppression ratio of Panax Notoginseng saponin R d is then 79%; Panax Notoginseng saponin R h1 has obvious inhibitory action to the hepatoma carcinoma cell of cultivating; Panax Notoginseng saponin R h2 has stronger anti-tumor activity, and can be reversed into non-cancerous cells by inducing cancer cell; In addition, arasaponin and Radix Notoginseng polysaccharide energy enhancing human body immunity function, have certain assosting effect to Therapeutic cancer;
Rhizoma Chuanxiong: for blood-activating and qi-promoting, wind-expelling pain-stopping, the pungent temperature of Rhizoma Chuanxiong is fragrant dry, walks and does not keep, can go loose, and the up mountain peak that reaches is pushed up; Enter blood system again, descendingly reach the sea of blood; Can tonifying liver blood, profit liver is dry, mends wind empty;
Radix Angelicae Sinensis: there is benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturizes laxation, anticancer, anti-ageing anti-old, immune effect; Also can be widely used in various tumor, especially gynecological tumor, stagnate with QI and blood, cohesion person is the most suitable for blood stasis; Radix Angelicae Sinensis and extract sodium ferulate thereof and Radix Angelicae Sinensis polysaccharide have obvious stimulation to monocytes/macrophages system, also have immune regulation and restitution to the body of immunologic hypofunction;
Flos Carthami: promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain, contributes to controlling amenorrhea, dysmenorrhea, lochia, obstruction of qi in the chest and cardialgia, the stagnant stomachache of the stasis of blood, the twinge of the breast side of body, traumatic injury, skin infection swells and ache curative effect; Containing Flos Carthami polysaccharide in Flos Carthami, can lymphocyte transformation be promoted, there is effect of enhancing immunity;
Rhizoma Curcumae: cure mainly coagulation of QI-blood, trusted subordinate's distending pain, lump in the abdomen, gather, dyspepsia does not disappear, women's blood stasis amenorrhea, traumatic injury are had a pain; Tuber claims " green filament Radix Curcumae ", has the function of promoting QI circulation for relieving depression, removing blood stasis with potent drugs, pain relieving; The curcumenol that Rhizoma Curcumae contains and curdione, directly can suppress to destroy tumor cell, but also can strengthen the immunogenicity of cell, thus promote that body is to the immunoreation of tumor;
Sanguis Draxonis: there is analgesic therapy of invigorating blood circulation, removing stasis to stop bleeding, effect of promoting tissue regeneration and ulcer healing;
Radix Gentianae: for damp and hot yellow cellulitis, swelling of the vulva pudendal pruritus, leukorrhagia, eczema pruritus, deafness, hypochondriac pain, bitter taste, convulsion with spasms; The erythricine that Radix Gentianae contains has significant antiphlogistic effects;
Herba Dendrobii: reinforcing stomach reg fluid, nourishing YIN and clearing away heat.Lose for cloudy impairment of body fluid, xerostomia excessive thirst, lack of appetite is retched, deficiency-heat after being ill, poor vision; Record according to " herbal classic ", the main damaging the spleen and stomach of Herba Dendrobii, eliminating impediment, the therapeutic method to keep the adverse QI flowing downwards, tonifying five ZANG-organs asthenia weakness and emaciation, reinforcing YIN-essence, takes thick the intestines and stomach for a long time;
Cordyceps: can the immunity of enhancing body, nourishing lung and kidney; The increased activity of natural killer cell can be made, thus play an important role in anticancer, viral infection resisting;
Radix Panacis Quinquefolii: boosting qi and nourishing yin, clearing away heat and promoting production of body fluid; Be the first-selected medical material of qi-tonifying health-care, can promote that serum albumin synthesizes, bone marrow protein synthesizes, organ protein synthesizes, improve immunity of organisms, anticancer grows, and effectively resists cancer;
Radix Clematidis: expelling wind and removing dampness, removing obstruction in the collateral to relieve pain; For rheumatic arthralgia, numb limbs and tense tendons, the contracture of muscle arteries and veins, joint stuffiness, bone is choked with sobs larynx;
Radix Glycyrrhizae: function cures mainly heat-clearing and toxic substances removing, expelling phlegm for arresting cough, gastral cavity abdomen etc.; Also can be used for being in harmonious proportion the strong of some drugs.
In the present invention, Gecko, Fructus Bruceae, flower of Radix Notoginseng, Rhizoma Curcumae have the effect killing cancerous cell; Raw first sheet, Squama Manis blood, Radix et Rhizoma Gynurae divaricatae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Radix Clematidis have effect of blood circulation promoting and blood stasis dispelling, wind-expelling pain-stopping; Flower of Radix Notoginseng, Flos Carthami, Cordyceps, Radix Panacis Quinquefolii have effect of enhancing immunity, also have certain assosting effect to antitumor; Radix Sophorae Tonkinensis is for heat clearing away of detoxifying; Radix Gentianae, Radix Glycyrrhizae have anti-inflammatory efficacy; Radix Glycyrrhizae, for being in harmonious proportion the property of medicine of drastic remedy, alleviates the stimulation of medicine to organs such as stomaches; Moringa, Brazilian Acai, Radix Panacis Quinquefolii, Herba Dendrobii can reinforcing stomach reg fluids, supplement vitamin and the mineral of needed by human body, improve that patient occurs in antagonism cancer disease process feel sick, become thin, weak, the ill symptoms such as to have no appetite, reduce medicine to the damage of human body; The present invention, by the reasonable compatibility of above-mentioned Chinese medicine, with strengthening the body resistance, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, blocking-up cancerous cell, improves immunity of organisms, finally reaches the object of curing uterus carcinoma.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but protection scope of the present invention is not limited to following examples:
One, the preparation of the Chinese medicine composition of uterus carcinoma is treated
Embodiment 1
Treat a Chinese medicine composition for uterus carcinoma, make by weight ratio primarily of following component: Gecko 6 parts, raw first sheet 7 parts, Squama Manis blood 3 parts, brucea 2 parts, Radix Sophorae Tonkinensis 2 parts, Moringa 13 parts, Brazilian Acai 12 parts, Radix et Rhizoma Gynurae divaricatae 10 parts, flower of Radix Notoginseng 20 parts, Rhizoma Chuanxiong 17 parts, Radix Angelicae Sinensis 17 parts, 5 parts, Flos Carthami, Rhizoma Curcumae 5 parts, brown 5 parts of blood, Radix Gentianae 3 parts, Herba Dendrobii 10 parts, Cordyceps 4 parts, Radix Panacis Quinquefolii 4 parts, Radix Clematidis 7 parts, 17 parts, Radix Glycyrrhizae.
What described Moringa was selected is Moringa rhizome.
The preparation method of above-mentioned Chinese medicine composition is:
(1) component in above-mentioned formula is taken by weight;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
Embodiment 2
Treat a Chinese medicine composition for uterus carcinoma, make by weight ratio primarily of following component: Gecko 3 parts, raw first sheet 4 parts, Squama Manis blood 1 part, brucea 1 part, Radix Sophorae Tonkinensis 1 part, Moringa 8 parts, Brazilian Acai 5 parts, Radix et Rhizoma Gynurae divaricatae 5 parts, flower of Radix Notoginseng 10 parts, Rhizoma Chuanxiong 8 parts, Radix Angelicae Sinensis 8 parts, 2 parts, Flos Carthami, Rhizoma Curcumae 2 parts, brown 2 parts of blood, Radix Gentianae 1 part, Herba Dendrobii 5 parts, Cordyceps 2 parts, Radix Panacis Quinquefolii 2 parts, Radix Clematidis 4 parts, 8 parts, Radix Glycyrrhizae.
What described Moringa was selected is Moringa rhizome.
The preparation method of above-mentioned Chinese medicine composition is:
(1) component in above-mentioned formula is taken by weight;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
Embodiment 3
Treat a Chinese medicine composition for uterus carcinoma, make by weight ratio primarily of following component: Gecko 10 parts, raw first sheet 10 parts, Squama Manis blood 5 parts, brucea 3 parts, Radix Sophorae Tonkinensis 3 parts, Moringa 18 parts, Brazilian Acai 16 parts, Radix et Rhizoma Gynurae divaricatae 15 parts, flower of Radix Notoginseng 30 parts, Rhizoma Chuanxiong 25 parts, Radix Angelicae Sinensis 25 parts, 7 parts, Flos Carthami, Rhizoma Curcumae 8 parts, brown 8 parts of blood, Radix Gentianae 5 parts, Herba Dendrobii 15 parts, Cordyceps 6 parts, Radix Panacis Quinquefolii 6 parts, Radix Clematidis 10 parts, 40 parts, Radix Glycyrrhizae.
What described Moringa was selected is Moringa rhizome.
The preparation method of above-mentioned Chinese medicine composition is:
(1) component in above-mentioned formula is taken by weight;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
Embodiment 4
Treat a Chinese medicine composition for uterus carcinoma, make by weight ratio primarily of following component: Gecko 4 parts, raw first sheet 5 parts, Squama Manis blood 2 parts, brucea 1 part, Radix Sophorae Tonkinensis 1 part, Moringa 10 parts, Brazilian Acai 7 parts, Radix et Rhizoma Gynurae divaricatae 7 parts, flower of Radix Notoginseng 15 parts, Rhizoma Chuanxiong 10 parts, Radix Angelicae Sinensis 10 parts, 3 parts, Flos Carthami, Rhizoma Curcumae 3 parts, brown 3 parts of blood, Radix Gentianae 2 parts, Herba Dendrobii 7 parts, Cordyceps 3 parts, Radix Panacis Quinquefolii 3 parts, Radix Clematidis 6 parts, 12 parts, Radix Glycyrrhizae.
What described Moringa was selected is Moringa rhizome.
The preparation method of above-mentioned Chinese medicine composition is:
(1) component in above-mentioned formula is taken by weight;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
Embodiment 5
Treat a Chinese medicine composition for uterus carcinoma, make by weight ratio primarily of following component: Gecko 8 parts, raw first sheet 9 parts, Squama Manis blood 4 parts, brucea 3 parts, Radix Sophorae Tonkinensis 3 parts, Moringa 17 parts, Brazilian Acai 14 parts, Radix et Rhizoma Gynurae divaricatae 13 parts, flower of Radix Notoginseng 25 parts, Rhizoma Chuanxiong 22 parts, Radix Angelicae Sinensis 22 parts, 6 parts, Flos Carthami, Rhizoma Curcumae 7 parts, brown 6 parts of blood, Radix Gentianae 4 parts, Herba Dendrobii 13 parts, Cordyceps 5 parts, Radix Panacis Quinquefolii 5 parts, Radix Clematidis 8 parts, 35 parts, Radix Glycyrrhizae.
What described Moringa was selected is Moringa rhizome.
The preparation method of above-mentioned Chinese medicine composition is:
(1) component in above-mentioned formula is taken by weight;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
Two, clinical practice
1, the selection of case:
Select traditional Chinese medical science uterus tumor patient, through 75 routine clinical observations.
(1) inclusive criteria:
A. the women of age between 38-65 year, 52.8 years old mean age.
B. tcm diagnosis uterus carcinoma is standard: limb is soft unable, seriously deficient, and lower abdomen drops, and suppresses swollen pain, uterus CT visual tumors.
C. can partner treatment, the patient of further consultation on time.
(2) exclusion standard
A. the age is below 38 years old or over-65s person.
B. other serious disease is suffered from
C. gestation or preparation gravid woman, women breast-feeding their children.
D. allergic constitution or to multi-medicament allergy sufferers.
E. not by regulation medication or therapy discontinued, cannot judge that curative effect or data are not congruent and affect the treatment or safety judgement person.
2, clinical trial:
(1) efficacy determination:
A. effective: body constitution strengthens, extremity are strong, and lower abdomen is uncomfortable obviously to be alleviated, and CT shows uterus tumor tumor body to be reduced, and other position does not find nascent tumor.
B. effective: weak symptom makes moderate progress, lower abdomen discomfort is alleviated to some extent, and uterus tumor tumor body has no growth, and other position does not find nascent tumor.
C. invalid: disease is unchanged, uterus tumor tumor body increases, or other position finds nascent tumor.
(2), during clinical experiment, other medicines and health nutrient is withdrawn.Take the preparation (each embodiment is observed through 15 routine patient clinicals) of embodiment 1 ~ 5 in the present invention, observing 3 months, is a course for the treatment of.Instructions of taking: every day 3 times, each 6 capsules, every capsules includes traditional Chinese medicine fine powder and extract 0.25 gram, warm water delivery service after meal, the results detailed in following table:
Group | Effective | Effectively | Invalid | Effective percentage |
Embodiment 1 | 7 | 7 | 1 | 93.3% |
Embodiment 2 | 6 | 6 | 3 | 80% |
Embodiment 3 | 6 | 6 | 3 | 80% |
Embodiment 4 | 7 | 6 | 2 | 86.7% |
Embodiment 5 | 6 | 7 | 2 | 86.7% |
Result shows: adopt the embodiment of the present invention 1 ~ 5 to treat, total effective rate reaches 86.7%, and general effect is better, the symptom such as obviously can improve that patient is weak, pain, anorexia, lower abdomen of becoming thin are uncomfortable, and the mental status is good.
Claims (7)
1. treat a Chinese medicine composition for uterus carcinoma, it is characterized in that, it is made by weight ratio primarily of following component:
Gecko 3 ~ 10 parts, raw first sheet 4 ~ 10 parts, Squama Manis blood 1 ~ 5 part, brucea 1 ~ 3 part, Radix Sophorae Tonkinensis 1 ~ 3 part, Moringa 8 ~ 18 parts, Brazilian Acai 5 ~ 16 parts, Radix et Rhizoma Gynurae divaricatae 5 ~ 15 parts, flower of Radix Notoginseng 10 ~ 30 parts, Rhizoma Chuanxiong 8 ~ 25 parts, Radix Angelicae Sinensis 8 ~ 25 parts, 2 ~ 7 parts, Flos Carthami, Rhizoma Curcumae 2 ~ 8 parts, brown 2 ~ 8 parts of blood, Radix Gentianae 1 ~ 5 part, Herba Dendrobii 5 ~ 15 parts, Cordyceps 2 ~ 6 parts, Radix Panacis Quinquefolii 2 ~ 6 parts, Radix Clematidis 4 ~ 10 parts, 8 ~ 40 parts, Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of uterus carcinoma according to claim 1, is characterized in that, it is made by weight ratio primarily of following component:
Gecko 4 ~ 8 parts, raw first sheet 5 ~ 9 parts, Squama Manis blood 2 ~ 4 parts, brucea 1 ~ 3 part, Radix Sophorae Tonkinensis 1 ~ 3 part, Moringa 10 ~ 17 parts, Brazilian Acai 7 ~ 14 parts, Radix et Rhizoma Gynurae divaricatae 7 ~ 13 parts, flower of Radix Notoginseng 15 ~ 35 parts, Rhizoma Chuanxiong 10 ~ 22 parts, Radix Angelicae Sinensis 10 ~ 22 parts, 3 ~ 6 parts, Flos Carthami, Rhizoma Curcumae 3 ~ 7 parts, brown 3 ~ 6 parts of blood, Radix Gentianae 2 ~ 4 parts, Herba Dendrobii 7 ~ 13 parts, Cordyceps 3 ~ 5 parts, Radix Panacis Quinquefolii 3 ~ 5 parts, Radix Clematidis 6 ~ 8 parts, 12 ~ 35 parts, Radix Glycyrrhizae.
3. the Chinese medicine composition for the treatment of uterus carcinoma according to claim 1, is characterized in that, it is made by weight ratio primarily of following component:
Gecko 6 parts, raw first sheet 7 parts, Squama Manis blood 3 parts, brucea 2 parts, Radix Sophorae Tonkinensis 2 parts, Moringa 13 parts, Brazilian Acai 12 parts, Radix et Rhizoma Gynurae divaricatae 10 parts, flower of Radix Notoginseng 20 parts, Rhizoma Chuanxiong 17 parts, Radix Angelicae Sinensis 17 parts, 5 parts, Flos Carthami, Rhizoma Curcumae 5 parts, brown 5 parts of blood, Radix Gentianae 3 parts, Herba Dendrobii 10 parts, Cordyceps 4 parts, Radix Panacis Quinquefolii 4 parts, Radix Clematidis 7 parts, 17 parts, Radix Glycyrrhizae.
4. the Chinese medicine composition of the treatment uterus carcinoma according to any one of claim 1 ~ 3, is characterized in that:
Described Chinese medicine composition adds by practice of pharmacy any dosage form that customary adjuvant makes clinical acceptance.
5. the Chinese medicine composition for the treatment of uterus carcinoma according to claim 4, is characterized in that:
Described dosage form is capsule.
6. the Chinese medicine composition for the treatment of uterus carcinoma according to claim 1, is characterized in that:
What described Moringa was selected is Moringa rhizome.
7. a kind of preparation method for the treatment of the Chinese medicine composition of uterus carcinoma according to claim 1, is characterized in that comprising the following steps:
(1) following component is taken by weight: Gecko 3 ~ 10 parts, raw first sheet 4 ~ 10 parts, Squama Manis blood 1 ~ 5 part, brucea 1 ~ 3 part, Radix Sophorae Tonkinensis 1 ~ 3 part, Moringa 8 ~ 18 parts, Brazilian Acai 5 ~ 16 parts, Radix et Rhizoma Gynurae divaricatae 5 ~ 15 parts, flower of Radix Notoginseng 10 ~ 30 parts, Rhizoma Chuanxiong 8 ~ 25 parts, Radix Angelicae Sinensis 8 ~ 25 parts, 2 ~ 7 parts, Flos Carthami, Rhizoma Curcumae 2 ~ 8 parts, brown 2 ~ 8 parts of blood, Radix Gentianae 1 ~ 5 part, Herba Dendrobii 5 ~ 15 parts, Cordyceps 2 ~ 6 parts, Radix Panacis Quinquefolii 2 ~ 6 parts, Radix Clematidis 4 ~ 10 parts, 8 ~ 40 parts, Radix Glycyrrhizae;
(2) first sheet and Cordyceps grind into powder is respectively given birth to;
(3) Fructus Bruceae extracts and makes Oleum Fructus Bruceae, for subsequent use;
(4) Brazilian Acai extracts and makes acai berry extract, for subsequent use;
(5) Gecko, raw first sheet powder, Squama Manis blood, Radix Sophorae Tonkinensis, Moringa, Radix et Rhizoma Gynurae divaricatae, flower of Radix Notoginseng, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Curcumae, blood brown, Radix Gentianae, Herba Dendrobii, Radix Panacis Quinquefolii, Radix Clematidis and Radix Glycyrrhizae, add the water of said components 6 ~ 10 times of weight, heating extraction 2 ~ 3 times, each 1 ~ 2 hour, filter, merging filtrate, filtrate is condensed into thick paste, add Cordyceps powder, acai berry extract and appropriate amount of starch, dry, pulverizing, get dry extract powder;
(6) get Oleum Fructus Bruceae, with the betacyclodextrin inclusion of 6 ~ 10 times of weight his cyclodextrin inclusion complex at double, add dried cream powder, magnesium stearate and microcrystalline Cellulose, mixing, makes granule, incapsulates, obtain capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610075509.1A CN105561202A (en) | 2016-02-03 | 2016-02-03 | Traditional Chinese medicine composition for treating uterus cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610075509.1A CN105561202A (en) | 2016-02-03 | 2016-02-03 | Traditional Chinese medicine composition for treating uterus cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105561202A true CN105561202A (en) | 2016-05-11 |
Family
ID=55872210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610075509.1A Pending CN105561202A (en) | 2016-02-03 | 2016-02-03 | Traditional Chinese medicine composition for treating uterus cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105561202A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103611094A (en) * | 2013-12-12 | 2014-03-05 | 王学玲 | Medicament for treating cervical cancer |
-
2016
- 2016-02-03 CN CN201610075509.1A patent/CN105561202A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103611094A (en) * | 2013-12-12 | 2014-03-05 | 王学玲 | Medicament for treating cervical cancer |
Non-Patent Citations (3)
Title |
---|
吴复苍: "《常见病遣方用药规律》", 31 October 2015, 中国医药科技出版社 * |
周绪堂: "《实用肿瘤诊疗手册》", 30 November 1997, 江西科学技术出版社 * |
李冈荣: "《汉方中草药对症图典 第4册》", 30 September 2015, 新疆科技卫生出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103893722B (en) | A kind of Chinese medicine composition and its preparation method treating sunburn | |
CN101095923B (en) | Chinese traditional medicine for treating ectopic pregnancy | |
CN103920034A (en) | Traditional Chinese medicine composition for alleviating side effects of chemotherapy of cancer patient and preparation method traditional Chinese medicine composition | |
CN102940808A (en) | Prescription medicine for treating lung cancer and preparation method | |
CN106266109A (en) | A kind of Chinese medicine composition treating urinary system calculus and preparation method thereof | |
CN105664022A (en) | Traditional Chinese medicine composition preparation for treating metrocarcinoma and preparing method of traditional Chinese medicine composition preparation | |
CN105770691A (en) | Medicinal preparation for treating cervical cancer and application thereof | |
CN104758701A (en) | Medicament for nursing treatment of stomach stones after lithotripsy and preparation method of medicament | |
CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
CN105561202A (en) | Traditional Chinese medicine composition for treating uterus cancer | |
CN105561201A (en) | Traditional Chinese medicine composition preparation for treating uterus cancer | |
CN105617264A (en) | Traditional Chinese medicine composition preparation for treating uterus cancer and preparation process thereof | |
CN105664023A (en) | Traditional Chinese medicine composition for treating metrocarcinoma and preparing technology of traditional Chinese medicine composition | |
CN105617265A (en) | Traditional Chinese medicine composition for treating uterus cancer and preparation method thereof | |
CN105963619A (en) | Traditional Chinese medicine composition for treating uterus coldness infertility | |
CN105031335A (en) | Medicament for nursing and treatment after microwave pulverization of gastric bezoars and its preparation method | |
CN104740396A (en) | Traditional Chinese medicine for treating kidney stones and preparation method of traditional Chinese medicine | |
CN105596862A (en) | Medicine used for treating and nursing postpartum dyspepsia caused by excessive eating or improper diet and preparation method thereof | |
CN105267895A (en) | Medicine for treating bovine postpartum blood stasis type placenta retension and preparing method thereof | |
CN103845719A (en) | Pharmaceutical composition for postpartum rehabilitation | |
CN106806680A (en) | Raw white side's prepared slices of Chinese crude drugs combination preparation, preparation method and assembly packaging | |
CN104666922A (en) | Chinese medicinal composition for treating irregular menstruation due to deficiency of qi in spleen and kidney | |
CN104784547A (en) | Traditional Chinese medicine composition having synergistic effect on radiotherapy and preparation method | |
CN104491561A (en) | Medicine used for treating pneumonia and preparation method of medicine | |
CN104587376A (en) | Drug for treating qi stagnation and blood stasis-type thoracic obstruction and preparation method of drug oral liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160511 |